Monomeric and dimeric GDF-5 show equal type I receptor binding and oligomerization capability and have the same biological activity
-
Christina Sieber
Abstract
Growth and differentiation factor 5 (GDF-5) is a homodimeric protein stabilized by a single disulfide bridge between cysteine 465 in the respective monomers, as well as by three intramolecular cysteine bridges within each subunit. A mature recombinant human GDF-5 variant with cysteine 465 replaced by alanine (rhGDF-5 C465A) was expressed in E. coli, purified to homogeneity, and chemically renatured. Biochemical analysis showed that this procedure eliminated the sole interchain disulfide bond. Surprisingly, the monomeric variant of rhGDF-5 is as potent in vitro as the dimeric form. This could be confirmed by alkaline phosphatase assays and Smad reporter gene activation. Furthermore, dimeric and monomeric rhGDF-5 show comparable binding to their specific type I receptor, BRIb. Studies on living cells showed that both the dimeric and monomeric rhGDF-5 induce homomeric BRIb and heteromeric BRIb/BRII oligomers. Our results suggest that rhGDF-5 C465A has the same biological activity as rhGDF-5 with respect to binding to, oligomerization of and signaling through the BMP receptor type Ib.
References
Amatayakul-Chantler, S., Qian, S.W., Gakenheimer, K., Bottinger, E.P., Roberts, A.B., and Sporn, M.B. (1994). [Ser77] transforming growth factor-β 1. Selective biological activity and receptor binding in mink lung epithelial cells. J. Biol. Chem.269, 27687–27691.Suche in Google Scholar
Canalis, E., Economides, A.N., and Gazzerro, E. (2003). Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr. Rev.24, 218–235.10.1210/er.2002-0023Suche in Google Scholar
Cheifetz, S., Weatherbee, J.A., Tsang, M.L., Anderson, J.K., Mole, J.E., Lucas, R., and Massague, J. (1987). The transforming growth factor-b system, a complex pattern of cross-reactive ligands and receptors. Cell48, 409–415.10.1016/0092-8674(87)90192-9Suche in Google Scholar
Daopin, S., Piez, K.A., Ogawa, Y., and Davies, D.R. (1992). Crystal structure of transforming growth factor-β2: an unusual fold for the superfamily. Science257, 369–373.10.1126/science.1631557Suche in Google Scholar
De Crescenzo, G., Pham, P.L., Durocher, Y., and O'Connor-McCourt, M.D. (2003). Transforming growth factor-β (TGF-β) binding to the extracellular domain of the type II TGF-β receptor: receptor capture on a biosensor surface using a new coiled-coil capture system demonstrates that avidity contributes significantly to high affinity binding. J. Mol. Biol.328, 1173–1183.10.1016/S0022-2836(03)00360-7Suche in Google Scholar
Evan, G.I., Lewis, G.K., Ramsay, G., and Bishop, J.M. (1985). Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell. Biol.5, 3610–3616.Suche in Google Scholar
Gilboa, L., Wells, R.G., Lodish, H.F., and Henis, Y.I. (1998). Oligomeric structure of type I and type II transforming growth factor β receptors: homodimers form in the ER and persist at the plasma membrane. J. Cell Biol.140, 767–777.10.1083/jcb.140.4.767Suche in Google Scholar
Gilboa, L., Nohe, A., Geissendorfer, T., Sebald, W., Henis, Y.I., and Knaus, P. (2000). Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors. Mol. Biol. Cell11, 1023–1035.10.1091/mbc.11.3.1023Suche in Google Scholar
Greenwald, J., Groppe, J., Gray, P., Wiater, E., Kwiatkowski, W., Vale, W., and Choe, S. (2003). The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. Mol. Cell11, 605–617.10.1016/S1097-2765(03)00094-7Suche in Google Scholar
Hart, P.J., Deep, S., Taylor, A.B., Shu, Z., Hinck, C.S., and Hinck, A.P. (2002). Crystal structure of the human TbR2 ectodomain-TGF-β3 complex. Nat. Struct. Biol.9, 203–208.Suche in Google Scholar
Henis, Y.I., Moustakas, A., Lin, H.Y., and Lodish, H.F. (1994). The types II and III transforming growth factor-β receptors form homo-oligomers. J. Cell Biol.126, 139–154.10.1083/jcb.126.1.139Suche in Google Scholar
Honda, J., Andou, H., Mannen, T., and Sugimoto, S. (2000). Direct refolding of recombinant human growth differentiation factor 5 for large-scale production process. J. Biosci. Bioeng.89, 582–589.10.1016/S1389-1723(00)80061-4Suche in Google Scholar
Hotten, G.C., Matsumoto, T., Kimura, M., Bechtold, R.F., Kron, R., Ohara, T., Tanaka, H., Satoh, Y., Okazaki, M., Shirai, T., et al. (1996). Recombinant human growth/differentiation factor 5 stimulates mesenchyme aggregation and chondrogenesis responsible for the skeletal development of limbs. Growth Factors13, 65–74.10.3109/08977199609034567Suche in Google Scholar PubMed
Husken-Hindi, P., Tsuchida, K., Park, M., Corrigan, A.Z., Vaughan, J.M., Vale, W.W., and Fischer, W.H. (1994). Monomeric activin A retains high receptor binding affinity but exhibits low biological activity. J. Biol. Chem.269, 19380–19384.10.1016/S0021-9258(17)32179-8Suche in Google Scholar
Israel, D.I., Nove, J., Kerns, K.M., Kaufman, R.J., Rosen, V., Cox, K.A., and Wozney, J.M. (1996). Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. Growth Factors13, 291–300.10.3109/08977199609003229Suche in Google Scholar
Jen, A., Madorin, K., Vosbeck, K., Arvinte, T., and Merkle, H.P. (2002). Transforming growth factor β-3 crystals as reservoirs for slow release of active TGF-β3. J. Control Release78, 25–34.10.1016/S0168-3659(01)00490-4Suche in Google Scholar
Jonk, L.J., Itoh, S., Heldin, C.H., ten Dijke, P., and Kruijer, W. (1998). Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-β, activin, and bone morphogenetic protein-inducible enhancer. J. Biol. Chem.273, 21145–21152.10.1074/jbc.273.33.21145Suche in Google Scholar
Kingsley, D.M. (1994). The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev.8, 133–146.10.1101/gad.8.2.133Suche in Google Scholar
Kirsch, T., Sebald, W., and Dreyer, M.K. (2000). Crystal structure of the BMP-2-BRIA ectodomain complex. Nat. Struct. Biol.7, 492–496.10.1038/75903Suche in Google Scholar
Knaus, P. and Sebald, W. (2001). Cooperativity of binding epitopes and receptor chains in the BMP/TGFβ superfamily. Biol. Chem.382, 1189–1195.10.1515/BC.2001.149Suche in Google Scholar
Lachmanovich, E., Shvartsman, D.E., Malka, Y., Botvin, C., Henis, Y.I., and Weiss, A.M. (2003). Co-localization analysis of complex formation among membrane proteins by computerized fluorescence microscopy: application to immunofluorescence co-patching studies. J. Microsc.212, 122–131.10.1046/j.1365-2818.2003.01239.xSuche in Google Scholar
Massague, J. (2000). How cells read TGF-β signals. Nat. Rev. Mol. Cell. Biol.1, 169–178.10.1038/35043051Suche in Google Scholar
McPherron, A.C. and Lee, S.J. (1993). GDF-3 and GDF-9: two new members of the transforming growth factor-β superfamily containing a novel pattern of cysteines. J. Biol. Chem.268, 3444–3449.10.1016/S0021-9258(18)53714-5Suche in Google Scholar
Nakamura, K., Shirai, T., Morishita, S., Uchida, S., Saeki-Miura, K., and Makishima, F. (1999). p38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/differentiation factor-5 in ATDC5 cells. Exp. Cell. Res.250, 351–363.10.1006/excr.1999.4535Suche in Google Scholar PubMed
Nickel, J., Kotzsch, A., Sebald, W., and Mueller, T.D. (2005). A single residue of GDF-5 defines binding specificity to BMP receptor IB. J. Mol. Biol.349, 933–947.10.1016/j.jmb.2005.04.015Suche in Google Scholar PubMed
Nishitoh, H., Ichijo, H., Kimura, M., Matsumoto, T., Makishima, F., Yamaguchi, A., Yamashita, H., Enomoto, S., and Miyazono, K. (1996). Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5. J. Biol. Chem.271, 21345–21352.10.1074/jbc.271.35.21345Suche in Google Scholar PubMed
Nohe, A., Hassel, S., Ehrlich, M., Neubauer, F., Sebald, W., Henis, Y.I., and Knaus, P. (2002). The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J. Biol. Chem.277, 5330–5338.10.1074/jbc.M102750200Suche in Google Scholar PubMed
Ogawa, Y., Schmidt, D.K., Dasch, J.R., Chang, R.J., and Glaser, C.B. (1992). Purification and characterization of transforming growth factor-β 2.3 and -β 1.2 heterodimers from bovine bone. J. Biol. Chem.267, 2325–2328.Suche in Google Scholar
O'Keeffe, G.W., Hanke, M., Pohl, J., and Sullivan, A.M. (2004). Expression of growth differentiation factor-5 in the developing and adult rat brain. Brain Res. Dev. Brain Res.151, 199–202.10.1016/j.devbrainres.2004.04.004Suche in Google Scholar PubMed
Piek, E., Heldin, C.H., and Ten Dijke, P. (1999). Specificity, diversity, and regulation in TGF-β superfamily signaling. FASEB J.13, 2105–2124.10.1096/fasebj.13.15.2105Suche in Google Scholar
Sammar, M., Stricker, S., Schwabe, G.C., Sieber, C., Hartung, A., Hanke, M., Oishi, I., Pohl, J., Minami, Y., Sebald, W., et al. (2004). Modulation of GDF5/BRI-b signalling through interaction with the tyrosine kinase receptor Ror2. Genes Cells9, 1227–1238.10.1111/j.1365-2443.2004.00799.xSuche in Google Scholar PubMed
Schlunegger, M.P. and Grutter, M.G. (1992). An unusual feature revealed by the crystal structure at 2.2 Å resolution of human transforming growth factor-β 2. Nature358, 430–434.Suche in Google Scholar
Schreuder, H., Liesum, A., Pohl, J., Kruse, M., and Koyama, M. (2005). Crystal structure of recombinant human growth and differentiation factor 5: evidence for interaction of the type I and type II receptor-binding sites. Biochem. Biophys. Res. Commun.329, 1076–1086.10.1016/j.bbrc.2005.02.078Suche in Google Scholar PubMed
Sebald, W., Nickel, J., Zhang, J.L., and Mueller, T.D. (2004). Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction. Biol. Chem.385, 697–710.10.1515/BC.2004.086Suche in Google Scholar PubMed
Seemann, P., Schwappacher, R., Kjaer, K.W., Krakow, D., Lehmann, K., Dawson, K., Stricker, S., Pohl, J., Ploger, F., Staub, E., et al. (2005). Activating and deactivating mutations in the receptor interaction site of GDF5 cause symphalangism or brachydactyly type A2. J. Clin. Invest.115, 2373–2381.10.1172/JCI25118Suche in Google Scholar PubMed PubMed Central
Shi, Y. and Massague, J. (2003). Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell113, 685–700.10.1016/S0092-8674(03)00432-XSuche in Google Scholar
Shimmi, O., Umulis, D., Othmer, H., and O'Connor, M.B. (2005). Facilitated transport of a Dpp/Scw heterodimer by Sog/Tsg leads to robust patterning of the Drosophila blastoderm embryo. Cell120, 873–886.10.1016/j.cell.2005.02.009Suche in Google Scholar PubMed PubMed Central
Vitt, U.A., Mazerbourg, S., Klein, C., and Hsueh, A.J. (2002). Bone morphogenetic protein receptor type II is a receptor for growth differentiation factor-9. Biol. Reprod.67, 473–480.10.1095/biolreprod67.2.473Suche in Google Scholar PubMed
©2006 by Walter de Gruyter Berlin New York
Artikel in diesem Heft
- Highlight: chronic oxidative stress and cancer
- Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress
- Does Helicobacter pylori cause gastric cancer via oxidative stress?
- Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis
- Mutagenesis and carcinogenesis caused by the oxidation of nucleic acids
- Concomitant suppression of hyperlipidemia and intestinal polyp formation by increasing lipoprotein lipase activity in Apc-deficient mice
- Cancer-preventive anti-oxidants that attenuate free radical generation by inflammatory cells
- Evidence for attenuated cellular 8-oxo-7,8-dihydro-2′-deoxyguanosine removal in cancer patients
- The roles of ATP in the dynamics of the actin filaments of the cytoskeleton
- Chiral distinction between the enantiomers of bicyclic alcohols by UDP-glucuronosyltransferases 2B7 and 2B17
- A structural model of 20S immunoproteasomes: effect of LMP2 codon 60 polymorphism on expression, activity, intracellular localisation and insight into the regulatory mechanisms
- Role of the kinin B1 receptor in insulin homeostasis and pancreatic islet function
- Comparative proteomic analysis of neoplastic and non-neoplastic germ cell tissue
- BID, an interaction partner of protein kinase CK2α
- Monomeric and dimeric GDF-5 show equal type I receptor binding and oligomerization capability and have the same biological activity
- Novel ketomethylene inhibitors of angiotensin I-converting enzyme (ACE): inhibition and molecular modelling
- Identification of trypsin I as a candidate for influenza A virus and Sendai virus envelope glycoprotein processing protease in rat brain
- A fluorescence assay for rapid detection of ligand binding affinity to HIV-1 gp41
Artikel in diesem Heft
- Highlight: chronic oxidative stress and cancer
- Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress
- Does Helicobacter pylori cause gastric cancer via oxidative stress?
- Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis
- Mutagenesis and carcinogenesis caused by the oxidation of nucleic acids
- Concomitant suppression of hyperlipidemia and intestinal polyp formation by increasing lipoprotein lipase activity in Apc-deficient mice
- Cancer-preventive anti-oxidants that attenuate free radical generation by inflammatory cells
- Evidence for attenuated cellular 8-oxo-7,8-dihydro-2′-deoxyguanosine removal in cancer patients
- The roles of ATP in the dynamics of the actin filaments of the cytoskeleton
- Chiral distinction between the enantiomers of bicyclic alcohols by UDP-glucuronosyltransferases 2B7 and 2B17
- A structural model of 20S immunoproteasomes: effect of LMP2 codon 60 polymorphism on expression, activity, intracellular localisation and insight into the regulatory mechanisms
- Role of the kinin B1 receptor in insulin homeostasis and pancreatic islet function
- Comparative proteomic analysis of neoplastic and non-neoplastic germ cell tissue
- BID, an interaction partner of protein kinase CK2α
- Monomeric and dimeric GDF-5 show equal type I receptor binding and oligomerization capability and have the same biological activity
- Novel ketomethylene inhibitors of angiotensin I-converting enzyme (ACE): inhibition and molecular modelling
- Identification of trypsin I as a candidate for influenza A virus and Sendai virus envelope glycoprotein processing protease in rat brain
- A fluorescence assay for rapid detection of ligand binding affinity to HIV-1 gp41